Transarterial radioembolization for liver tumors as neoadjuvant therapy: three case reports

Transarterial radioembolization (TARE) with yttrium-90 microspheres is a palliative locoregional treatment, minimally invasive for liver tumors. The neoadjuvant aim of this treatment is still controversial, however, selected cases with lesions initially considered unresectable have been enframed as...

Descripción completa

Detalles Bibliográficos
Autores principales: Carvalho, Vithor de Oliveira, Galastri, Francisco Leonardo, Affonso, Breno Boueri, Falsarella, Priscila Mina, Valle, Leonardo Guedes Moreira, Ferraz-Neto, Ben-Hur, de Rezende, Marcelo Bruno, da Motta-Leal-Filho, Joaquim Maurício, Garcia, Rodrigo Gobbo, Nasser, Felipe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Israelita de Ensino e Pesquisa Albert Einstein 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032884/
https://www.ncbi.nlm.nih.gov/pubmed/32130329
http://dx.doi.org/10.31744/einstein_journal/2020RC4990
Descripción
Sumario:Transarterial radioembolization (TARE) with yttrium-90 microspheres is a palliative locoregional treatment, minimally invasive for liver tumors. The neoadjuvant aim of this treatment is still controversial, however, selected cases with lesions initially considered unresectable have been enframed as candidates for curative therapy after hepatic transarterial radioembolization. We report three cases in which the hepatic transarterial radioembolization was used as neoadjuvant therapy in an effective way, allowing posterior potentially curative therapies.

Ejemplares similares